Page last updated: 2024-09-05

maropitant and glycopyrrolate

maropitant has been researched along with glycopyrrolate in 1 studies

Compound Research Comparison

Studies
(maropitant)
Trials
(maropitant)
Recent Studies (post-2010)
(maropitant)
Studies
(glycopyrrolate)
Trials
(glycopyrrolate)
Recent Studies (post-2010) (glycopyrrolate)
7436561,198404522

Protein Interaction Comparison

ProteinTaxonomymaropitant (IC50)glycopyrrolate (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.0005
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0002
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0002
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0001
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Burke, JE; Hess, RS; Silverstein, DC1

Trials

1 trial(s) available for maropitant and glycopyrrolate

ArticleYear
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
    Journal of the American Veterinary Medical Association, 2021, 12-15, Volume: 260, Issue:S1

    Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting

2021